|
 |
|
| Home > In Vitro Diagnostics |
| |
| |
|
| |
 In Vitro Diagnostics Market Research Reports |
Potassium: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of Potassium testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
 |
|
$750.00 |
| |
|
|
|
Sodium: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, US
This new report from Venture Planning Group provides analysis of Sodium testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Total Protein: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of Total Protein testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Triglycerides: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of Triglycerides testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Troponin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of Troponin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Uric Acid: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of Uric Acid testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Cortisol: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of Cortisol testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Estradiol: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of Estradiol testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
FSH: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of FSH testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
HCG: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of HCG testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Gastrin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of Gastrin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
LH: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of LH testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Progesterone: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of Progesterone testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
PTH/IO PTH: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of PTH/IO PTH testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Prolactin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of Prolactin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
T3: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of T3 testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
T3 Uptake: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of T3 Uptake testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Free T3: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from Venture Planning Group provides analysis of Free T3 testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
|